Dr Andrew Brooks

Dr Andrew Brooks

Dr Andrew Brooks' interests are in understanding the molecular nature of cell communication and transmission of signals from the outside of cells to the nucleus of cells to regulate gene expression, cell growth, and cell differentiation. Understanding these fundamental mechanisms will lead to a greater understanding of disease states and will ultimately lead to vastly improved therapeutics and outcomes for patients.

Read more ›
Professor Riccardo Dolcetti

Professor Riccardo Dolcetti

Riccardo Dolcetti received his medical degree in Italy in 1983 and then trained as an Oncologist at the University of Ferrara where he specialized in Medical Oncology in 1986. Upon completing his medical training in 1987, he established a research group at the Centro Riferimento Oncologico – National Cancer Institute (CRO-NCI), Aviano, Italy initially focussing on oncogenesis in lymphoproliferative disorders and later to cancer immunology.

Read more ›
Dr Pascal Duijf

Dr Pascal Duijf

Cancer cells often missegregate their chromosomes during cell division, or mitosis. This phenomenon is termed chromosome instability. Dr Duijf’s research group focuses on identifying the mechanisms of chromosome instability in cancer cells. His research in this area is aimed at developing new approaches to improve the diagnosis and treatment of cancer.

Read more ›
Professor Ian Frazer FRS

Professor Ian Frazer AC, FRS, FAA

Professor Ian Frazer was trained as a renal physician and a clinical immunologist in Edinburgh, Scotland, before emigrating to Melbourne in 1981 to pursue studies in viral immunology and autoimmunity at the Walter and Eliza Hall Institute of Medical Research, with Professor Ian Mackay.

Read more ›
Professor Maher Gandhi

Professor Maher Gandhi

Leukaemia Foundation Queensland Chair in Blood Cancer Research Professor Maher Gandhi has established an international reputation studying immunity and identification of novel biomarkers in lymphoma.

Read more ›
Associate Professor Nikolas Haass

Professor Nikolas Haass

Prof Nikolas Haass is a clinician scientist specializing in skin cancers. His interests is the understanding of (1) cell-cell and cell-matrix interactions of melanoma with its microenvironment (2) signalling pathways in melanoma, particularly with regards to identifying novel melanoma therapies and (3) the characterization of melanoma cell subpopulations.

Read more ›
Associate Professor Michelle Hill

Associate Professor Michelle Hill

Associate Professor Hill's interdisciplinary research in translational oncology focuses on two areas; (1) biomarker discovery and development into clinical tests, and (2) molecular mechanism of obesity on cancer development and progression, with current focus on cholesterol-rich membrane microdomains.

Read more ›
Associate Professor Kiarash Khosrotehrani

Associate Professor Kiarash Khosrotehrani

Associate Professor Khosrotehrani is a clinical scientist interested in skin biology, regenerative medicine and skin cancer.

Read more ›
Dr Graham Leggatt

Dr Graham Leggatt

Dr Graham Leggatt was born and raised in Brisbane where he completed a Bachelor of Science with honours at The University of Queensland in 1989.

Read more ›
Dr Stephen Mattarollo, Research Fellow

Dr Stephen Mattarollo, Research Fellow

Dr Mattarollo is a cancer immunologist, with a strong interest in developing combination immunotherapies for blood cancers.

Read more ›
Dr Roberta Mazzieri, Senior Research Fellow

Dr Roberta Mazzieri, Senior Research Fellow

Dr Mazzieri's work focusses on targeting pro-tumoural macrophages to inhibit tumour progression with a specific focus on breast cancer metastasis.

Read more ›
Dr Andrew Moore

Dr Andrew Moore

Dr Moore is a Paediatric Oncologist at the Lady Cilento Children's Hospital and Group Leader of the Childhood Leukaemia Research Laboratory at the University of Queensland Diamantina Institute, TRI. He is also Director of the Queensland Children's Tumour Bank, one of only 3 biobanks in Australia dedicated to childhood cancer.

Read more ›
Associate Professor Nicholas Saunders

Associate Professor Nicholas Saunders

Associate Professor Nicholas Saunders trained as a pharmacologist at the University of Western Australia under the supervision of Professor Rodney Minchin and Professor Ken Illett.

Read more ›
Dr Linda Scott

Dr Linda Scott

Linda's research in the last twenty-two years has focused on various aspects of hematopoiesis, including transcriptional regulation during myelopoiesis, the regulation of hematopoietic stem and progenitor cell trafficking in vivo, and, most recently, the molecular pathogenesis of human hematologic malignancies (in particular, the myeloproliferative neoplasms, or MPNs).

Read more ›
Dr Fiona Simpson

Dr Fiona Simpson

Dr Fiona Simpson completed her PhD on cellular trafficking with Professor Margaret Robinson at the University of Cambridge, UK.

Read more ›
Dr Chris Slape

Dr Chris Slape

Dr Slape’s research career has had two primary objectives: to understand the mechanisms of transformation of chronic pre-leukemia conditions to acute leukemia, and to investigate the disease stem cells in pre-leukemia conditions to find therapeutic targets for both phases of haematological disease.

Read more ›
Dr James Wells

Dr James Wells

Dr James Wells received his PhD from King’s College London in 2004, working with Dr Joanna Galea-Lauri and Professor Farzin Farzaneh on DC-based vaccines for cancer therapy.

Read more ›